InspireMD Stock Price - NSPR

0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
InspireMD Inc New NSPR AMEX Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 1.11 1.06 1.12 1.09 1.11 19:59:36
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
201 56,437 $ 1.10 $ 62,249 359,062 0.7401 - 11.00
Last Trade Time Type Quantity Stock Price Currency
19:59:36 156 $ 1.11 USD

InspireMD Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 4.03M 3.63M $ -7.24M -64.39 - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
122.51k $ - 0.00% 1.00 -

more financials information »

InspireMD News

Loading Messages....

Latest NSPR Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NSPR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.,680-0.04-3.48%
1 Month1.251.650.98011.28457,609-0.14-11.2%
3 Months0.79521.650.7841.10400,3450.314839.59%
6 Months2.185.300.74011.48311,803-1.07-49.08%
1 Year8.8011.000.74014.64375,353-7.69-87.39%
3 Years4,042.504,952.500.7401247.971,650,712-4,041.39-99.97%
5 Years5,602.289492,750.000.74011,458.721,258,720-5,601.18-99.98%

InspireMD Description

InspireMD Inc is the United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.